Subscribe to MDT Magazine News

Draft Guidance for Industry and Food and Drug Administration Staff - Class II Special Controls Guidance Document: In Vitro Diagnostic Devices for Bacillus spp. Detection

May 18, 2011 6:31 am | by U.S. Food & Drug Administration | Comments

This draft special controls guidance document was developed to support the proposed classification of in vitro diagnostic device for Bacillus spp. detection, a previously unclassified type of preamendments device, into class II, as recommended by the...

Abiomed reports fiscal 4Q loss, Impella sales rise

May 18, 2011 5:45 am | by The Associated Press | Comments

Abiomed posted a loss for the fourth quarter which, unlike last year, did not have the benefit of the sale of its stake in World Heart Corp. Yet revenue rose sharply, giving a boost to company shares before the market opened Wednesday.Without the $6.4 million sale this year, the heart device...

Cepheid Appoints LABSCO as US Small Hospital Distributor

May 18, 2011 5:32 am | by Bio-Medicine.Org | Comments

SUNNYVALE, Calif., May 18, 2011 /- Cepheid (NASDAQ: CPHD ) today announced it has entered into an agreement with LABSCO ( ), the largest privately held distributor of clinical products in the United States, to become its US distribution partner for Cepheid's GeneXpert®...


Favorable Clinical Study Results Reported With Dual Anti-Platelet Therapy After LAA Closure With WATCHMAN® Device

May 18, 2011 4:33 am | by Boston Scientific | Comments

Results for Boston Scientific WATCHMAN device presented at EuroPCR


Reportlinker Adds Hong Kong SMBG Devices and Strips Market

May 18, 2011 1:32 am | by Bio-Medicine.Org | Comments

NEW YORK, May 18, 2011 /- announces that a new market research report is available in its catalogue: Hong Kong SMBG Devices and Strips Market...


Wellpoint declares quarterly dividend

May 17, 2011 2:45 pm | by The Associated Press | Comments

Wellpoint Inc., a health insurer based in Indianapolis, declared a regular quarterly dividend of 25 cents on Tuesday. The company said it will pay the dividend June 24 to shareholders of record as of June 10.

Shire buys Advanced BioHealing for $750M

May 17, 2011 2:35 pm | by Mass High Tech: The Journal of New England Technology | Comments

Advanced BioHealing Inc., the Connecticut biotech that filed for a $200 million IPO at the beginning of May, has been scooped up before its IPO for $750 million cash by Shire plc, the Irish company with its Human Genetic Therapies business presence in Lexington.

SME Announces Faculty Advisor Professional Development Awardees

May 17, 2011 12:40 pm | by Society of Manufacturing Engineers | Comments

DEARBORN, Mich., May 17, 2011 — The Student Relations Committee of the Society of Manufacturing Engineers (SME) has awarded its inaugural Faculty Advisor Professional Development Award to educators committed to the next generation of manufacturing professionals. More


Foundation Medicine forms alliance with Celgene

May 17, 2011 12:39 pm | by Mass High Tech: The Journal of New England Technology | Comments

Cancer genomics tests developed by Cambridge-based Foundation Medicine Inc. are part of a collaboration with biopharmaceuticals firm Celgene Corp., which will apply the tests to its own clinical drug trials.

University Hospitals Seidman Cancer Center Announces $30 Million Proton Therapy Center

May 17, 2011 12:38 pm | by Bio-Medicine.Org | Comments

CLEVELAND, May 17, 2011 /- University Hospitals Seidman Cancer Center announced plans to establish a $30 million proton therapy center, becoming one of an elite group of cancer centers in the country to offer this revolutionary technology. Proton therapy is an advanced type of radiation...


Positive Results from Long-Term Phase 3 Study of Avanafil Featured at American Urological Association Annual Meeting

May 17, 2011 12:38 pm | by Bio-Medicine.Org | Comments

MOUNTAIN VIEW, Calif., May 17, 2011 /- VIVUS, Inc. (NASDAQ: VVUS ) today announced that positive results from a pivotal phase 3 open-label clinical trial evaluating long-term safety and efficacy of the investigational drug avanafil for the treatment of erectile dysfunction (ED) were...


Allina Hospitals & Clinics to Save on Commodity Supply Purchases Through Novation's New Committed Portfolio

May 17, 2011 12:38 pm | by Bio-Medicine.Org | Comments

IRVING, Texas, May 17, 2011 /- Allina Hospitals & Clinics, which serves patients throughout Minnesota and western Wisconsin, has simplified its commodity supply management strategies with the help of VHA Inc, the national health care network and Novation, VHA's supply contracting...


U.S. Chamber Inducts PCMA President & CEO Mark Merritt to its Committee of Top Trade Assoc. Executives

May 17, 2011 12:38 pm | by Bio-Medicine.Org | Comments

WASHINGTON, May 17, 2011 /PRNewswire-USNewswire/ -- The U.S. Chamber of Commerce has welcomed Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt into its elite "Association Committee of 100," which includes America's top trade association executives....


Food Allergies Common among Children and Linked to Environmental Allergies and Asthma Later in Life, Suggests Largest-Ever National Allergy Study

May 17, 2011 12:33 pm | by Bio-Medicine.Org | Comments

MADISON, N.J., May 17, 2011 /- Early results from the largest cross-sectional national allergy study ever conducted, to be released later this month, demonstrate that food allergies commonly occur in infants and toddlers, while environmental allergies, such as to dust, ragweed and mold,...


ORNL energy harvesters transform waste into electricity

May 17, 2011 9:35 am | by I-Micronews | Comments

Billions of dollars lost each year as waste heat from industrial processes can be converted into electricity with a technology being developed at the Department of Energy's Oak Ridge National Laboratory.


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.